QR Code

Exposure-Response and Clinical Outcome Modeling of Inhaled Budesonide/Formoterol Combination in Asthma Patients

Exposure-response and clinical outcome (CO) model for inhaled budesonide/formoterol was developed to quantify the relationship among pharmacokinetics (PK), pharmacodynamics (PD) and CO of the drugs and evaluate the covariate effect on model parameters. Sputum eosinophils cationic proteins (ECP) and...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Hyun-moon Back, Jong Bong Lee, Anhye Kim, Seon-Jong Park, Junyeong Kim, Jung-woo Chae, Seung Soo Sheen, Leonid Kagan, Hae-Sim Park, Young-Min Ye, Hwi-yeol Yun
Hōputu: Artigo
Reo:Inglês
I whakaputaina: MDPI AG 2020-04-01
Rangatū:Pharmaceutics
Ngā marau:
moderate asthma
population analysis
budesonide/formoterol
asthma control test
dose optimization
Urunga tuihono:https://www.mdpi.com/1999-4923/12/4/336
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite